Solana Co — Director's Dealing 2019

Nov 29, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)
CIK: 0001610853
Period of Report: 2019-11-27

Reporting Person: ANDREEFF DANE (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-11-27	Class A Common Stock	A	317762	$0.35	Acquired	620435	Indirect
2019-11-27	Class A Common Stock	A	65721	$0.35	Acquired	132004	Indirect
2019-11-27	Class A Common Stock	A	187946	$0.35	Acquired	349099	Indirect

Footnotes

F1: Acquired from the Issuer on November 27, 2019 pursuant to a Subscription Agreement dated November 22, 2019. The Subscription Agreement and the issuance of the securities thereunder was approved by the Issuer's Board of Directors.

F2: Reflects a 5-for-1 reverse stock split of the Issuer's Class A Common Stock effected on January 22, 2018, which was not reflected in the Reporting Person's prior filings.

F3: The shares are held by Maple Leaf Partners, L.P. ("MLP"). The reporting person is the managing member of Maple Leaf Capital I, LLC ("Maple Leaf Capital"), the general partner of MLP, and as such may be deemed to beneficially own the securities owned by MLP. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

F4: The shares are held by Maple Leaf Partners I, L.P. ("MLP I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLP I, and as such may be deemed to beneficially own the securities held by MLP I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

F5: The shares are held by Maple Leaf Discovery I, L.P. ("MLD I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLD I, and as such may be deemed to beneficially own the securities held by MLD I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.